Illinois HB4930 bans the sale and distribution of kratom and tianeptine products unless approved by the FDA.
HB4930, known as the Protect Communities from Unregulated Substances Act, prohibits the dispensing, distribution, manufacturing, or sale of kratom and tianeptine products for human use unless approved by the U.S. Food and Drug Administration. The bill imposes a civil penalty of $10,000 per violation and authorizes enforcement by the Attorney General. It defines "kratom" and "tianeptine product" and includes severability and an immediate effective date.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.